Omeros reported $-1.12 in EPS Earnings Per Share for its fiscal quarter ending in June of 2024.





Eps Change Date
Adma Biologics USD 0.19 0.01 Mar/2026
Alnylam Pharmaceuticals USD 1.99 0.74 Mar/2026
BioMarin Pharmaceutical USD 0.76 0.3 Mar/2026
Cytokinetics USD -1.67 0.17 Mar/2026
Gilead Sciences USD 2.03 0.17 Mar/2026
Heron Therapeutics USD -0.02 0.02 Dec/2025
Immunic USD -0.1 0.03 Dec/2025
Insmed USD -0.76 0.78 Mar/2026
Knight Therapeutics CAD 0.13 0.22 Mar/2026
MacroGenics USD -0.58 0.36 Mar/2026
Omeros USD -1.12 0.37 Jun/2024
Pacira USD 0.6 0.54 Mar/2026
Pfizer USD 0.75 0.09 Mar/2026
Rockwell Medical USD 0.01 0.07 Jun/2024
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sarepta Therapeutics USD 3.16 6.74 Mar/2026
United Therapeutics USD 5.82 1.88 Mar/2026
Vertex Pharmaceuticals USD 4.47 0.56 Mar/2026
Xoma USD -1.59 2.43 Sep/2024